Wharton S, Kuk JL, Luszczynski M, Kamran E, Christensen RAG
Patients could have fewer in-person visits but more frequent digital interactions
First GLP-1 tablet for weight loss approved in the UK (Wegovy)
One common question is which medication to choose, so it helps to read our full comparison of semaglutide vs tirzepatide and how the two leading GLP-1 medications differ in action, results, and side effects before your visit
The drugs are among several pharmacological options that providers have to treat endocrine diseases
After consideration of the comments received, we are finalizing our proposal to remove the COVID-19 Vaccination Coverage Among HCP measure from the Hospital OQR and ASCQR Programs beginning with the CY 2024 reporting period/CY 2026 payment determination